Menu

Blog Posts

Exclusive

Welch Likely to Introduce Senate Version of Matsui’s 340B PATIENTS Act As Soon As Next Week

Views
U.S. Sen. Peter Welch (D-VT) could introduce a Senate version of the 340B PATIENTS Act as early as next week.
A Vermont Democrat and longtime 340B advocate is expected to soon introduce a Senate version of the 340B Pharmaceutical Access [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Experts Forecast Impact of November Elections on 340B Program, Drug Pricing and the Larger Economy

Views
340B Report hosted a subscriber-only webinar on the 2024 elections on Sept. 5.
November will bring an epic battle for both the U.S. presidency and control in Congress, both of which could have [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Webinar — Navigating 340B Contract Pharmacy Restrictions: The Latest Developments, Field Insights, and Mitigation Efforts

Views
Join Us September 18th at 1pm EST

SPONSORED CONTENT

Join Ravin Consultants for an insightful webinar on the ever-changing 340B landscape. We will explore the latest contract pharmacy restrictions and state responses as well as mitigation strategies and alternative distribution models. In addition to getting an update on the latest developments from

…
Read More »

HHS Asks D.C. Federal Court to Rule for Drugmakers in Contract Pharmacy Lawsuits, Ties Outcomes to Kalderos 340B Rebate Case

Views
HHS filed status reports in five separate ongoing drug industry cases before a federal district court.
The U.S. government is asking a federal district court in Washington, D.C., to rule for drugmakers in four separate lawsuits [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

State Contract Pharmacy Lawsuit Weekly Roundup: Updates in Arkansas, Maryland, Missouri, West Virginia 

Views
Key motions were filed this week in state contract pharmacy litigation in Arkansas, Maryland, Missouri and West Virginia.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Merck Offers Refunds to 340B Providers for Overcharges of Inhaler in Fourth Notice This Year

Views
Drugmaker Merck announced it will refund 340B covered entities for certain overcharges.
Pharmaceutical manufacturer Merck has announced it will refund 340B covered entities for certain overcharges of its inhaler, Proventil HFA, during [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

RxParadigm

Q: Tell us some interesting details about your company’s history.

RxParadigm, founded in 2021 by CEO Mesfin Tegenu, is built on nearly 30 years of industry expertise, delivering innovative pharmacy

…
Read More »

Expert Tip from PharmaForce

Views
img
img

TIP: Maintain an accurate and comprehensive provider list to maximize 340B program effectiveness and compliance.

An outdated

…
Read More »

J&J’s 340B Rebate Vendor to Host In-Person Training Next Monday Despite Government’s Objection to Proposal

Views
Beacon Channel Management is holding multiple trainings on its 340B rebate platform.
The new industry vendor administrating Johnson & Johnson’s (J&J’s) contested 340B rebate proposal is hosting an in-person training for third [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Bayer to Extend Contract Pharmacy Restrictions to Federal Grantees, Providers and Advocates Voice Concerns About Recent Trend

Views
Bayer wordmark on side of building
Bayer will no longer exempt federal grantees from its 340B contract pharmacy policy as of Oct. 1.
German drugmaker Bayer will no longer exempt federal grantees from its 340B contract pharmacy policy beginning Oct. 1—the same day [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »